Orexin/hypocretin system: Obesity, narcolepsy and beyond

Drug News and Perspectives

Volumn 15, Issue 3, 2002, Pages 166-174

  Kwok, Ernest H ^a   Dun, Nae J ^a  

^a East Tennessee State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROTRANSMITTER; OREXIN A; OREXIN B; RECEPTOR;

APPETITE; ARTICLE; CARDIOVASCULAR DISEASE; FEEDING BEHAVIOR; FOOD INTAKE; HUMAN; HYPOTHALAMUS; NARCOLEPSY; NERVE FIBER; NONHUMAN; OBESITY; SLEEP DISORDER; SLEEP WAKING CYCLE; SYMPATHETIC TONE; WAKEFULNESS;

EID: 0036267825     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2002.15.3.840013     Document Type: Article

References (133)

1. Overweight and obesity in the United States: Prevalence and trends, 1960-1994
2. Varying body mass index cutoff points to describe overweight prevalence among U.S. adults: NHANES 111 (1988 to 1994)
3. Losing the battle of the bulge: Causes and consequences of increasing obesity
4. Current estimates of the economic cost of obesity in the United States
5. Obesity: How big a problem?
6. Social and economic effects of body weight in the United States
7. Hypothalamic lesions and adiposity in the rat
8. Hypothalamic control of food intake in rats and cats
9. Recovery of feeding and drinking after lateral hypothalamus lesions
10. The lateral hypothalamic area revisited: Ingestive behavior
11. Reciprocal relationships of the lateral and ventromedial hypothalamus in the regulation of food intake
12. The physiology of motivation. 1954
13. Is interruption of the nigrostriatal dopamine system producing the "lateral hypothalamus syndrome"?
14. Nigrostriatal bundle damage and the lateral hypothalamic syndrome
15. Sensory neglect produced by lateral hypothalamic damage
16. Further analysis of sensory inattention following lateral hypothalamic damage in rats
17. Comparison of electrolytic and ibotenic acid lesions in the lateral hypothalamus
18. Recovery from the failure to eat produced by hypothalamic lesions
19. Food intake and utilization in lateral hypothalamically lesioned rats
20. Reorganization of neural peptidergic systems in the median eminence after hypophysectomy
21. Hypothalamic obesity: The myth of the ventromedial nucleus
22. Overview of the most prevalent hypothalamus-specific mRNAs, as identified by directional tag PCR subtraction
23. The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity
24. Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior
25. Localization of disinhibition-dementia-Parkinsonism-amyotrophy complex to 17q21-22
26. Localization of the gene for rapidly progressive autosomal dominant Parkinsonism and dementia with pallido-pontonigral degeneration to chromosome 17q21
27. Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/ orexin
28. Hypothalamic hypocretin (orexin): Robust innervation of the spinal cord
29. The hypocretins are weak agonists at recombinant human orexin-1 and orexin-2 receptors
30. Hypocretin/orexin, sleep and narcolepsy
31. The hypocretin/orexin ligand-receptor system: Implications for sleep and sleep disorders
32. The Hypocretin/orexin story
33. Neurons containing hypocretin (orexin) project to multiple neuronal systems
34. Distribution of orexin neurons in the adult rat brain
35. Orexins: A role in medullary sympathetic outflow
36. Distribution and quantification of immunoreactive orexin A in rat tissues
37. Orexin A-like immunoreactivity in the rat brain
38. Immunohistochemical localization and biochemical characterization of hypocretin/orexin-related peptides in the central nervous system of the frog Rana ridibunda
39. Differential distribution of orexin-A and orexin-B immunoreactivity in the rat brain and spinal cord
40. Distribution of hypocretin-(orexin) immunoreactivity in the central nervous system of Syrian hamsters (Mesocricetus auratus)
41. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems
42. Distribution of orexin-A and orexin-B (hypocretins) in the rat spinal cord
43. Hypocretin receptor protein and mRNA expression in the dorsolateral pons of rats
44. Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord
45. Differential expression of orexin receptors 1 and 2 in the rat brain
46. Distribution of orexin receptor mRNA in the rat brain
47. Orexin/hypocretin excites the histaminergic neurons of the tubero-mammillary nucleus
48. Mechanisms of orexin-induced depolarizations in rat dorsal motor nucleus of vagus neurones in vitro
49. Orexin A activates locus coeruleus cell firing and increases arousal in the rat
50. Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system
51. Hypocretin/orexin depolarizes and decreases potassium conductance in locus coeruleus neurons
52. Orexins/hypocretins excite rat sympathetic preganglionic neurons in vivo and in vitro
53. Orexin depolarizes rat hypothalamic paraventricular nucleus neurons
54. Orexin A preferentially excites glucose-sensitive neurons in the lateral hypothalamus of the rat in vitro
55. Orexin A excites serotonergic neurons in the dorsal raphe nucleus of the rat
56. Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell-line using FLIPR
57. Effect of intracerebroventricular orexin-B on food intake in sheep
58. Stimulation of feeding behavior and food consumption in the goldfish, Carassius auratus, by orexin-A and orexin-B
59. Cloning of porcine prepro-orexin cDNA and effects of an intramuscular injection of synthetic porcine orexin-B on jeed intake in young pigs
60. Inhibition of food intake by central injection of anti-orexin antibody in fasted rats
61. A selective orexin-I receptor antagonist reduces food consumption in male and female rats
62. SB-334867, a selective orexin-I receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats
63. The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic and monosodium glutamate-treated mice
64. Coexpression of Agrp and NP Y in fasting-activated hypothalamic neurons
65. Leptin activates hypothalamic CART neurons projecting to the spinal cord
66. Effects of the obese gene product on body weight regulation in ob/ob mice
67. Weight-reducing effects of the plasma protein encoded by the obese gene
68. Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks
69. Positional cloning of the mouse obese gene and its human homologue
70. Identification and expression cloning of a leptin receptor, OB-R
71. Leptin receptor- and STAT3-immunoreactivities in hypocretin/orexin neurones of the lateral hypothalamus
72. Morphological evidence for neural interactions between leptin and orexin in the hypothalamus
73. Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: A novel circuit implicated in metabolic and endocrine regulations
74. Down regulation of the prepro-orexin gene expression in genetically obese mice
75. Hypothalamic hypocretin/orexin and neuropeptide Y: Divergent interaction with energy depletion and leptin
76. Orexin A activates leptin-responsive neurons in the arcuate nucleus
77. Evidence that NPY1 receptors are involved in stimulation of feeding by orexins (hypocretins) in sated rats
78. Evidence of NPY Y5 receptor involvement in food intake elicited by orexin A in sated rats
79. Orexin-induced food intake involves neuropeptide Ypathway
80. Hypocretin 1 in the lateral hypothalamus activates key feeding-regulatory brain sites
81. Orexin-A immunoreactive neurons in the rat hypothalamus do not contain neuronal nitric oxide synthase (nNOS)
82. Characterization of CART neurons in the rat and human hypothalamus
83. A role for melanin-concentrating hormone in the central regulation of feeding behaviour
84. Immunohistochemical localization of novel CART peptides in rat hypothalamus, pituitary and adrenal gland
85. Hypothalamic CART is a new anorectic peptide regulated by leptin
86. Neurochemical characterization of hypothalamic cocaine-amphetamine-regulated transcript neurons
87. Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: Relationship to the neuropeptide Y and agouti gene-related protein systems
88. Distribution of galaninlike immunoreactivity in the rat central nervous system
89. Immunocytochemical localization of atrial natriuretic factor, galanin and calcitonin gene-related peptide within the rat interpeduncular nucleus
90. Galanin: Stimulation of ,feeding induced by medial hypothalamic injection of this novel peptide
91. Orexin (hypocretin) neurons contain dynorphin
92. Endorphins and food intake: Kappa opioid receptor agonists and hyperphagia
93. Vagal preganglionic neurones
94. Stimulation of gastric acid secretion by centrally administered orexin-A in conscious rats
95. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y
96. Effect of lateral cerebroventricular injection of the appetite-stimulating neuropeptide, orexin and neuropeptide Y, on the various behavioral activities of rats
97. Chronic intracerebroventricular administration of orexin-A to rats increases food intake in daytime, but has no effect on body weight
98. Independent feeding and metabolic actions of orexins in mice
99. The effect of the orexins on food intake: Comparison with neuropeptide Y, melanin-concentrating hormone and galanin
100. Effects of single and chronic intracerebroventricular administration of the orexins on feeding in the rat
101. Feeding response to central orexins
102. Food intake elicited by central administration of orexins/hypocretins: Identification of hypothalamic sites of action
103. Insulin-induced hypoglycemia increases preprohypocretin (orexin) mRNA in the rat lateral hypothalamic area
104. Neurons containing orexin in the lateral hypothalamic area of the adult rat brain are activated by insulin-induced acute hypoglycemia
105. Lowering glucose concentrations increases cytosolic Ca(2+) in orexin neurons of the rat lateral hypothalamus
106. Hypothalamic orexin expression: Modulation by blood glucose and feeding
107. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene
108. Narcolepsy in orexin knockout mice: Molecular genetics of sleep regulation
109. Hypocretin-2-saporin lesions of the lateral hypothalamus produce narcoleptic-like sleep behavior in the rat
110. Genetic and familial aspects of narcolepsy
111. Narcolepsy and immunity
112. Hypocretin (orexin) deficiency in human narcolepsy
113. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains
114. Reduced number of hypocretin neurons in human narcolepsy
115. The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats
116. Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons
117. Microdialysis perfusion of orexin-A in the basal forebrain increases wakefulness in freely behaving rats
118. Orexins/hypocretins excite basal forebrain cholinergic neurones
119. Orexins (hypocretins) directly excite tuberomammillary neurons
120. Orexin-a activates phospholipase C- and protein kinase C-mediated Ca2+ signaling in dopamine neurons of the ventral tegmental area
121. Effects of lateral preoptic area application of orexin-A on sleep-wakefulness
122. Effects on sleep and wakefulness of the injection of hypocretin-1 (orexin-A) into the laterodorsal tegmental nucleus of the cat
123. Prepro-hypocretin (prepro-orexin) expression is unaffected by short-term sleep deprivation in rats and mice
124. Hypothalamic orexin A-immunoreactive neurons project to the rat dorsal medulla
125. Effects of orexins on the hypothalamic-pituitary-adrenal system
126. Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin
127. Orexins, orexigenic hypothalamic neuropeptides, suppress the pulsatile secretion of luteinizing hormone in ovariectomized female rats
128. Pressor effects of orexins injected intracisternally and to rostral ventrolateral medulla of anesthetized rats
129. Cardiovascular regulatory actions of the hypocretins in brain
130. Sympathetic and cardiovascular actions of orexins in conscious rats
131. Increased body-mass index in patients with narcolepsy
132. Autonomic nervous system function in narcolepsy
133. Autonomic control of cardiovascular reflexes in narcolepsy